Literature DB >> 1442673

High prevalence and persistence of cytotoxin-positive Helicobacter pylori strains in a population with high prevalence of atrophic gastritis.

J G Fox1, P Correa, N S Taylor, N Thompson, E Fontham, F Janney, M Sobhan, B Ruiz, F Hunter.   

Abstract

Helicobacter pylori is strongly associated with both chronic gastritis and duodenal ulcer. Certain strains of H. pylori produce a vacuolating cytotoxin in vitro. At New Orleans Charity Hospital, concentrated culture supernatants from 119 of 144 (83%) H. pylori strains isolated from 86 patients at high risk of developing gastric cancer, caused vacuolization in HeLa S3 cells. Cytotoxin activity was neutralized by acid (pH 4) and basic (pH 10) solutions and proteases, and was precipitable by (NH4)2SO4, which suggests that the cytotoxin is a protein. In 66 of 86 (76.7%) patients, the H. pylori strains isolated from single or multiple sequential gastric biopsies had a vacuolating cytotoxin. These cytotoxin-positive H. pylori strains were isolated from 69% of patients with diffuse antral gastritis and 89% of patients with chronic atrophic gastritis. The latter lesion is considered a precursor of gastric cancer. The cytotoxicity persisted in sequential biopsies over an interval of several months, indicating persistence of these strains in the gastric mucosa. Fifty-eight percent (7/12) of the sera from cytotoxin-positive H. pylori-infected patients neutralized cytotoxin activity, whereas 20% (1/5) of sera from patients with H. pylori cytotoxin-negative strains and none of five H. pylori-negative patients' sera neutralized cytotoxin activity. The relevance of this cytotoxin in the pathogenesis of H. pylori-induced gastritis requires further study.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1442673

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  23 in total

1.  Analysis of Helicobacter pylori vacA gene and serum antibodies to VacA in Japan.

Authors:  D Shirasaka; N Aoyama; K Satonaka; K Shirakawa; H Yoshida; T Sakai; T Ikemura; Y Shinoda; M Sakashita; M Miyamoto; K Yahiro; A Wada; H Kurazono; T Hirayama; M Kasuga
Journal:  Dig Dis Sci       Date:  2000-04       Impact factor: 3.199

2.  Study of T-lymphocyte subsets, nitric oxide, hexosamine and Helicobacter pylori infection in patients with chronic gastric diseases.

Authors:  Hui Zhang; Shu-Lin Jiang; Xi-Xian Yao
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

3.  Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection.

Authors:  J Parsonnet; G D Friedman; N Orentreich; H Vogelman
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

4.  cagA and vacA status and influence of Helicobacter pylori infection on serum oxidative DNA damage in Iranian patients with peptic ulcer disease.

Authors:  Z Khodaii; S M H Ghaderian; R Akbarzadeh Najar; H Nejati; A S Tabatabaei Panah
Journal:  Ir J Med Sci       Date:  2010-08-20       Impact factor: 1.568

5.  Profile of Helicobacter pylori cytotoxin derived from two areas of Japan with different prevalence of atrophic gastritis.

Authors:  S Ito; T Azuma; H Murakita; M Hirai; H Miyaji; Y Ito; Y Ohtaki; Y Yamazaki; M Kuriyama; Y Keida; Y Kohli
Journal:  Gut       Date:  1996-12       Impact factor: 23.059

6.  Helicobacter pylori genotypes may determine gastric histopathology.

Authors:  C Nogueira; C Figueiredo; F Carneiro; A T Gomes; R Barreira; P Figueira; C Salgado; L Belo; A Peixoto; J C Bravo; L E Bravo; J L Realpe; A P Plaisier; W G Quint; B Ruiz; P Correa; L J van Doorn
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

7.  Major virulence factors, VacA and CagA, are commonly positive in Helicobacter pylori isolates in Japan.

Authors:  S Maeda; K Ogura; H Yoshida; F Kanai; T Ikenoue; N Kato; Y Shiratori; M Omata
Journal:  Gut       Date:  1998-03       Impact factor: 23.059

8.  Helicobacter pylori and histopathological changes of gastric mucosa in Uganda population with varying prevalence of stomach cancer.

Authors:  Henry Wabinga
Journal:  Afr Health Sci       Date:  2005-09       Impact factor: 0.927

Review 9.  Role of Helicobacter pylori in gastrointestinal disease: implications for primary care of a revolution in management of dyspepsia.

Authors:  B C Delaney
Journal:  Br J Gen Pract       Date:  1995-09       Impact factor: 5.386

10.  CagA and VacA Helicobacter pylori antibodies in gastric cancer.

Authors:  R Suriani; M Colozza; E Cardesi; D Mazzucco; M Marino; S Grosso; S Sanseverinati; I Venturini; A Borghi; M Luisa Zeneroli
Journal:  Can J Gastroenterol       Date:  2008-03       Impact factor: 3.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.